CPT® Code 81178

Molecular genetic testing is a critical procedure used to identify mutations in specific genes associated with various genetic disorders, including spinocerebellar ataxia (SCA). This condition is characterized by a progressive degeneration of the cerebellum and spinal cord, leading to a range of neurological symptoms. The ATXN1 gene, which is the focus of this analysis, is located on the short (p) arm of chromosome 6 at position 22.3 (6p22.3). It encodes the protein ataxin 1, which plays a role in neuronal function and is distributed throughout the body. In individuals with SCA, mutations in the ATXN1 gene can lead to an abnormal expansion of a specific DNA sequence known as a trinucleotide repeat, which consists of the nucleotides cytosine, adenine, and guanine (CAG). Normally, this repeat occurs between 4 to 39 times; however, in SCA1, the repeat can expand to between 40 to 80 times or more. The presence of these expanded alleles is associated with the onset of symptoms, which can include uncoordinated gait (ataxia), muscle stiffness, tremors, dysarthria (difficulty speaking), dysphagia (difficulty swallowing), and various cognitive challenges. Symptoms typically emerge in mid-adulthood, although they can appear earlier in individuals with a higher number of repeats. The CPT® Code 81178 specifically reports the analysis of the ATXN1 gene to evaluate and detect these abnormal (expanded) alleles, facilitating diagnosis and management of the condition.